Patient-derived Tumor Xenograft (PDTX) Injection, Bank Maintenance, and Developmental Therapeutics
6:40
Results: PDTX Model Characterization
8:05
Conclusion
Transkript
The overall goal of this subcutaneous Patient Derived Tumor Xenograft procedure is to the study the efficacy of novel therapies predictive biomarker discovery and drug resistant pathways in tumors. This method can help answer key questions in the
Bu içeriğe erişmek için giriş yapın veya ücretsiz denemenizi başlatın
Utilizing patient-derived tumors in a subcutaneous preclinical model is an excellent way to study the efficacy of novel therapies, predictive biomarker discovery, and drug resistant pathways. This model, in the drug development process, is essential in determining the fate of many novel anti-cancer therapies prior to clinical investigation.